Jeffrey K. Mito

2.2k total citations
45 papers, 1.4k citations indexed

About

Jeffrey K. Mito is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Jeffrey K. Mito has authored 45 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Jeffrey K. Mito's work include Sarcoma Diagnosis and Treatment (15 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Genomics and Diagnostics (5 papers). Jeffrey K. Mito is often cited by papers focused on Sarcoma Diagnosis and Treatment (15 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Genomics and Diagnostics (5 papers). Jeffrey K. Mito collaborates with scholars based in United States, South Korea and Belgium. Jeffrey K. Mito's co-authors include David G. Kirsch, Edus H. Warren, Stanley R. Riddell, Rebecca D. Dodd, Leona A. Doyle, Yan Ma, Vickie Y. Jo, Leslie G. Dodd, William C. Eward and Brian E. Brigman and has published in prestigious journals such as Science, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Jeffrey K. Mito

44 papers receiving 1.4k citations

Peers

Countries citing papers authored by Jeffrey K. Mito

Since Specialization

Citations

This map shows the geographic impact of Jeffrey K. Mito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey K. Mito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey K. Mito more than expected).

Fields of papers citing papers by Jeffrey K. Mito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey K. Mito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey K. Mito. The network helps show where Jeffrey K. Mito may publish in the future.

Co-authorship network of co-authors of Jeffrey K. Mito

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey K. Mito. A scholar is included among the top collaborators of Jeffrey K. Mito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey K. Mito. Jeffrey K. Mito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Science, Medicine, and Cytology: an educational program of the Diversity, Equity, and Inclusion Committee of the American Society of Cytopathology 2024 ·Journal of the American Society of Cytopathology ·(unknown), Ronald Balassanian, Natalie Banet, Güliz A. Barkan, (unknown), Evita Henderson‐Jackson, Elizabeth Jenkins, Ayşe Kılıç, Lisa A. Lai, (unknown), Nora Morgenstern, Jeffrey K. Mito, Michelle D. Reid, (unknown), (unknown), Alarice Lowe	0
2	Triage options for positive high-risk HPV results from HPV-based cervical cancer screening: a review of the potential alternatives to Papanicolaou test cytology 2024 ·Journal of the American Society of Cytopathology ·Michael J. Thrall, Erin McCarthy, Jeffrey K. Mito, Jianyu Rao	5
3	Validation of targeted next‐generation sequencing of cell‐free DNA from archival cerebrospinal fluid specimens for the detection of somatic variants in cancer involving the leptomeninges: Cytopathologic and radiographic correlation 2023 ·Cancer Cytopathology ·Alexander J. Neil, Ugonma Chukwueke, (unknown), (unknown), Vanesa Rojas‐Rudilla, Danielle K. Manning, Jeffrey K. Mito, Edmund S. Cibas, Lynette M. Sholl	3
4	Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention 2022 ·The Journal of Pathology ·Ju‐Yoon Yoon, David B. Chapel, (unknown), Xiaohua Qian, Jeffrey K. Mito, Neil S. Horowitz, Alexander Miron, T. Rinda Soong, Wa Xian, Christopher P. Crum	6
5	Leveraging thoughtful quality metric selection for individual and system improvements: the atypical category and use of dashboards 2022 ·Journal of the American Society of Cytopathology ·Vanda F. Torous, Jeffrey K. Mito, Paul A. VanderLaan	2
6	SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance 2021 ·eLife ·Maurizio Fazio, Ellen van Rooijen, Michelle Dang, Glenn van de Hoek, Julien Ablain, Jeffrey K. Mito, Song Yang, Andrew Thomas, Michael Jonathan, (unknown), (unknown), Patrizia Pessina, Charles K. Kaufman, Yi Zhou, Richard M. White, Leonard I. Zon	9
7	Recurrent co‐alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma progression and poor prognosis 2020 ·Pigment Cell & Melanoma Research ·Maurizio Fazio, Ellen van Rooijen, Jeffrey K. Mito, (unknown), (unknown), Song Yang, Leonard I. Zon	8
8	Human tumor genomics and zebrafish modeling identify SPRED1 loss as a driver of mucosal melanoma 2018 ·Science ·Julien Ablain, Mengshu Xu, Harriet Rothschild, Richard C. Jordan, Jeffrey K. Mito, Brianne H. Daniels, Caitlin Bell, Nancy M. Joseph, Hong Wu, Boris C. Bastian, Leonard I. Zon, Iwei Yeh	97
9	Radiation-Associated Sarcomas 2018 ·Surgical pathology clinics ·Jeffrey K. Mito, Devarati Mitra, Leona A. Doyle	24
10	MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes 2014 ·Journal of Clinical Investigation ·Mohit Sachdeva, Jeffrey K. Mito, Chang‐Lung Lee, Minsi Zhang, Zhizhong Li, Rebecca D. Dodd, (unknown), Lixia Luo, Yan Ma, David Van Mater, Rebecca A. Gladdy, Dina Lev, Diana M. Cardona, David G. Kirsch	84
11	NF1 Deletion Generates Multiple Subtypes of Soft-Tissue Sarcoma That Respond to MEK Inhibition 2013 ·Molecular Cancer Therapeutics ·Rebecca D. Dodd, Jeffrey K. Mito, William C. Eward, Rhea Chitalia, Mohit Sachdeva, Yan Ma, Jordi Barretina, Leslie G. Dodd, David G. Kirsch	62
12	Optimization of a Widefield Structured Illumination Microscope for Non-Destructive Assessment and Quantification of Nuclear Features in Tumor Margins of a Primary Mouse Model of Sarcoma 2013 ·PLoS ONE ·Henry L. Fu, Jenna L. Mueller, (unknown), Jeffrey K. Mito, David G. Kirsch, Nirmala Ramanujam, J. Quincy Brown	27
13	Imaging Primary Mouse Sarcomas After Radiation Therapy Using Cathepsin-Activatable Fluorescent Imaging Agents 2013 ·International Journal of Radiation OncologyBiologyPhysics ·Kyle C. Cuneo, Jeffrey K. Mito, (unknown), Jorge M. Ferrer, Yongbaek Kim, (unknown), Moungi G. Bawendi, Brian E. Brigman, David G. Kirsch	17
14	Quantitative Segmentation of Fluorescence Microscopy Images of Heterogeneous Tissue: Application to the Detection of Residual Disease in Tumor Margins 2013 ·PLoS ONE ·Jenna L. Mueller, Zachary T. Harmany, Jeffrey K. Mito, Stephanie A. Kennedy, Yongbaek Kim, Leslie G. Dodd, Joseph Geradts, David G. Kirsch, Rebecca Willett, J. Quincy Brown, Nirmala Ramanujam	13
15	Distinct and Overlapping Sarcoma Subtypes Initiated from Muscle Stem and Progenitor Cells 2013 ·Cell Reports ·Jordan M. Blum, (unknown), Zhizhong Li, David Van Mater, Brian J. Bennett, Mohit Sachdeva, Irina V. Lagutina, Minsi Zhang, Jeffrey K. Mito, Leslie G. Dodd, Diana M. Cardona, Rebecca D. Dodd, Nerissa T. Williams, Yan Ma, Christoph Lepper, Corinne M. Linardic, Sayan Mukherjee, Gerard C. Grosveld, Chen‐Ming Fan, David G. Kirsch	49
16	A Novel Imaging System Permits Real-time in Vivo Tumor Bed Assessment After Resection of Naturally Occurring Sarcomas in Dogs 2012 ·Clinical Orthopaedics and Related Research ·William C. Eward, Jeffrey K. Mito, (unknown), (unknown), Jorge M. Ferrer, David G. Kirsch, Brian E. Brigman	35
17	Selective Enhancement of Donor Hematopoietic Cell Engraftment by the CXCR4 Antagonist AMD3100 in a Mouse Transplantation Model 2010 ·PLoS ONE ·Yubin Kang, Benny J. Chen, Divino Deoliveira, Jeffrey K. Mito, Nelson J. Chao	44
18	Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma 2009 ·PLoS ONE ·Jeffrey K. Mito, Richard F. Riedel, Leslie G. Dodd, Guy Lahat, Alexander J. Lazar, Rebecca D. Dodd, Lars Stangenberg, William C. Eward, Francis J. Hornicek, Sam S. Yoon, Brian E. Brigman, Tyler Jacks, Dina Lev, Sayan Mukherjee, David G. Kirsch	59
19	C19orf48 Encodes a Minor Histocompatibility Antigen Recognized by CD8+ Cytotoxic T Cells from Renal Cell Carcinoma Patients 2008 ·Clinical Cancer Research ·Scott S. Tykodi, Nobuharu Fujii, Nathalie Vigneron, Sharon Lu, Jeffrey K. Mito, (unknown), Jeffrey Chou, Lilien N. Voong, John A. Thompson, Brenda M. Sandmaier, Peter Cresswell, Benoı̂t Van den Eynde, Stanley R. Riddell, Edus H. Warren	43
20	An Antigen Produced by Splicing of Noncontiguous Peptides in the Reverse Order 2006 ·Science ·Edus H. Warren, Nathalie Vigneron, Marc A. Gavin, Pierre G. Coulie, Vincent Stroobant, Alexandre Dalet, Scott S. Tykodi, (unknown), Jeffrey K. Mito, Stanley R. Riddell, Benoı̂t J. Van den Eynde	160

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact